Published in J Surg Res on April 28, 2008
VEGF is critical for stem cell-mediated cardioprotection and a crucial paracrine factor for defining the age threshold in adult and neonatal stem cell function. Am J Physiol Heart Circ Physiol (2008) 1.44
Superior therapeutic potential of young bone marrow mesenchymal stem cells by direct intramyocardial delivery in aged recipients with acute myocardial infarction: in vitro and in vivo investigation. J Tissue Eng (2011) 0.85
Pre-transplantation specification of stem cells to cardiac lineage for regeneration of cardiac tissue. Stem Cell Rev (2009) 0.83
Efficient labeling in vitro with non-ionic gadolinium magnetic resonance imaging contrast agent and fluorescent transfection agent in bone marrow stromal cells of neonatal rats. Mol Med Rep (2015) 0.77
Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2006) 19.43
Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet (2004) 9.35
Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age. Nature (2007) 7.72
Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet (2006) 7.33
Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ Res (2006) 4.14
Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. J Am Coll Cardiol (2007) 4.05
Telomere dysfunction induces environmental alterations limiting hematopoietic stem cell function and engraftment. Nat Med (2007) 2.41
IL-6 and APPs: anti-inflammatory and immunosuppressive mediators. Immunol Today (1997) 2.37
A relationship between vascular endothelial growth factor, angiogenesis, and cardiac repair after muscle stem cell transplantation into ischemic hearts. J Am Coll Cardiol (2007) 2.26
The injured child is resistant to multiple organ failure: a different inflammatory response? J Trauma (2002) 2.26
Differentiation, survival, and function of embryonic stem cell derived endothelial cells for ischemic heart disease. Circulation (2007) 2.21
Nonmyeloablative stem cell therapy enhances microcirculation and tissue regeneration in murine inflammatory bowel disease. Gastroenterology (2006) 1.98
In vitro and in vivo effects of bone marrow stem cells on cardiac structure and function. J Mol Cell Cardiol (2006) 1.81
Combining pharmacological mobilization with intramyocardial delivery of bone marrow cells over-expressing VEGF is more effective for cardiac repair. J Mol Cell Cardiol (2006) 1.58
Influence of sex and age on mods and cytokines after multiple injuries. Shock (2007) 1.56
Gender differences in injury induced mesenchymal stem cell apoptosis and VEGF, TNF, IL-6 expression: role of the 55 kDa TNF receptor (TNFR1). J Mol Cell Cardiol (2006) 1.48
Sex differences in the myocardial inflammatory response to ischemia-reperfusion injury. Am J Physiol Endocrinol Metab (2004) 1.44
Neutralization of endogenous IL-6 suppresses induction of IL-1 receptor antagonist. J Immunol (1995) 1.40
Pretreatment with adult progenitor cells improves recovery and decreases native myocardial proinflammatory signaling after ischemia. Shock (2006) 1.28
Colonic subepithelial myofibroblasts in mucosal inflammation and repair: contribution of bone marrow-derived stem cells to the gut regenerative response. J Gastroenterol (2005) 1.12
17Beta-estradiol downregulates Kupffer cell TLR4-dependent p38 MAPK pathway and normalizes inflammatory cytokine production following trauma-hemorrhage. Mol Immunol (2006) 1.09
Sex dimorphisms in activated mesenchymal stem cell function. Shock (2006) 1.05
Stem cells and the regeneration of the aging cardiovascular system. Circ Res (2007) 1.05
The role of IL-4 and IL-6 in IL-1-dependent cartilage matrix degradation. Br J Rheumatol (1995) 0.98
Vascular endothelial growth factor improves myocardial functional recovery following ischemia/reperfusion injury. J Surg Res (2008) 0.97
Bone marrow cell transplantation in clinical perspective. J Mol Cell Cardiol (2005) 0.95
Bone marrow mononuclear cell therapy limits myocardial infarct size through vascular endothelial growth factor. Basic Res Cardiol (2004) 0.93
Stem cell transplantation as a therapeutic approach to organ failure. J Surg Res (2005) 0.92
Stem cells and myocardial repair. J Am Coll Surg (2002) 0.90
Thyroid hormone attenuates cardiac remodeling and improves hemodynamics early after acute myocardial infarction in rats. Eur J Cardiothorac Surg (2007) 0.90
Transplantation of microencapsulated genetically modified xenogeneic cells augments angiogenesis and improves heart function. Gene Ther (2007) 0.88
Estradiol administration improves splanchnic perfusion following trauma-hemorrhage and sepsis. Arch Surg (2002) 0.86
Neonatal stem cells exhibit specific characteristics in function, proliferation, and cellular signaling that distinguish them from their adult counterparts. Am J Physiol Regul Integr Comp Physiol (2008) 0.85
Influence of ERK activation on decreased chemotaxis of mature human cord blood monocyte-derived dendritic cells to CCL19 and CXCL12. Blood (2006) 0.80
Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure. Circulation (2006) 4.69
Human mesenchymal stem cells stimulated by TNF-alpha, LPS, or hypoxia produce growth factors by an NF kappa B- but not JNK-dependent mechanism. Am J Physiol Cell Physiol (2008) 2.18
Human progenitor cells from bone marrow or adipose tissue produce VEGF, HGF, and IGF-I in response to TNF by a p38 MAPK-dependent mechanism. Am J Physiol Regul Integr Comp Physiol (2006) 1.69
Stem cells as a potential future treatment of pediatric intestinal disorders. J Pediatr Surg (2008) 1.57
Estrogen receptor-alpha mediates acute myocardial protection in females. Am J Physiol Heart Circ Physiol (2006) 1.55
Cytokines in necrotizing enterocolitis. Shock (2006) 1.53
Sex differences in the myocardial inflammatory response to acute injury. Shock (2005) 1.52
Role of tumor necrosis factor receptor 1 in sex differences of stem cell mediated cardioprotection. Ann Thorac Surg (2009) 1.51
Experimental therapies for hypoxia-induced pulmonary hypertension during acute lung injury. Shock (2006) 1.50
Gender differences in injury induced mesenchymal stem cell apoptosis and VEGF, TNF, IL-6 expression: role of the 55 kDa TNF receptor (TNFR1). J Mol Cell Cardiol (2006) 1.48
Sex differences in the myocardial inflammatory response to ischemia-reperfusion injury. Am J Physiol Endocrinol Metab (2004) 1.44
VEGF is critical for stem cell-mediated cardioprotection and a crucial paracrine factor for defining the age threshold in adult and neonatal stem cell function. Am J Physiol Heart Circ Physiol (2008) 1.44
Transforming growth factor-α enhances stem cell-mediated postischemic myocardial protection. Ann Thorac Surg (2011) 1.42
High passage number of stem cells adversely affects stem cell activation and myocardial protection. Shock (2006) 1.40
Sex steroids and stem cell function. Mol Med (2008) 1.34
17-beta-Estradiol decreases p38 MAPK-mediated myocardial inflammation and dysfunction following acute ischemia. J Mol Cell Cardiol (2006) 1.29
Pretreatment with adult progenitor cells improves recovery and decreases native myocardial proinflammatory signaling after ischemia. Shock (2006) 1.28
Preconditioning mesenchymal stem cells with transforming growth factor-alpha improves mesenchymal stem cell-mediated cardioprotection. Shock (2010) 1.28
Estrogen receptor beta mediates increased activation of PI3K/Akt signaling and improved myocardial function in female hearts following acute ischemia. Am J Physiol Regul Integr Comp Physiol (2009) 1.23
In the adult mesenchymal stem cell population, source gender is a biologically relevant aspect of protective power. Surgery (2007) 1.22
Endogenous estrogen attenuates pulmonary artery vasoreactivity and acute hypoxic pulmonary vasoconstriction: the effects of sex and menstrual cycle. Am J Physiol Endocrinol Metab (2007) 1.19
Tumor necrosis factor receptor 1 signaling resistance in the female myocardium during ischemia. Circulation (2006) 1.18
Cellular and molecular mechanisms of sex differences in renal ischemia-reperfusion injury. Cardiovasc Res (2005) 1.17
Differential IL-6 and VEGF secretion in adult and neonatal mesenchymal stem cells: role of NFkB. Cytokine (2008) 1.16
STAT3 mediates bone marrow mesenchymal stem cell VEGF production. J Mol Cell Cardiol (2007) 1.14
The role of estrogen in cardiovascular disease. J Surg Res (2003) 1.13
Cytokines in epithelial-mesenchymal transition: a new insight into obstructive nephropathy. J Urol (2008) 1.13
Mechanisms of sex differences in TNFR2-mediated cardioprotection. Circulation (2008) 1.13
IL-18 binding protein-expressing mesenchymal stem cells improve myocardial protection after ischemia or infarction. Proc Natl Acad Sci U S A (2009) 1.12
Mesenchymal stem cells enhance the viability and proliferation of human fetal intestinal epithelial cells following hypoxic injury via paracrine mechanisms. Surgery (2009) 1.11
Endothelial STAT3 plays a critical role in generalized myocardial proinflammatory and proapoptotic signaling. Am J Physiol Heart Circ Physiol (2007) 1.11
TNF-alpha-dependent bilateral renal injury is induced by unilateral renal ischemia-reperfusion. Am J Physiol Heart Circ Physiol (2002) 1.11
Role of endogenous testosterone in myocardial proinflammatory and proapoptotic signaling after acute ischemia-reperfusion. Am J Physiol Heart Circ Physiol (2004) 1.10
IL-18 neutralization ameliorates obstruction-induced epithelial-mesenchymal transition and renal fibrosis. Kidney Int (2009) 1.10
Animal models of myocardial and vascular injury. J Surg Res (2009) 1.09
Sex dimorphisms in activated mesenchymal stem cell function. Shock (2006) 1.05
beta-Blockers in sepsis: reexamining the evidence. Shock (2009) 1.05
Embryonic stem cells attenuate myocardial dysfunction and inflammation after surgical global ischemia via paracrine actions. Am J Physiol Heart Circ Physiol (2008) 1.05
Neonatal iron deficiency causes abnormal phosphate metabolism by elevating FGF23 in normal and ADHR mice. J Bone Miner Res (2014) 1.05
Signaling via GPR30 protects the myocardium from ischemia/reperfusion injury. Surgery (2010) 1.05
Selective estrogen receptor-alpha and estrogen receptor-beta agonists rapidly decrease pulmonary artery vasoconstriction by a nitric oxide-dependent mechanism. Am J Physiol Regul Integr Comp Physiol (2008) 1.04
Deficiency of TNFR1 protects myocardium through SOCS3 and IL-6 but not p38 MAPK or IL-1beta. Am J Physiol Heart Circ Physiol (2006) 1.04
Hypoxic pulmonary vasoconstriction and pulmonary artery tissue cytokine expression are mediated by protein kinase C. Am J Physiol Lung Cell Mol Physiol (2004) 1.04
Brief exposure to exogenous testosterone increases death signaling and adversely affects myocardial function after ischemia. Am J Physiol Regul Integr Comp Physiol (2006) 1.04
Therapeutic applications of mesenchymal stem cells to repair kidney injury. J Urol (2010) 1.03
Gender, sex hormones and pulmonary hypertension. Pulm Circ (2013) 1.02
Dihydroceramide-based response to hypoxia. J Biol Chem (2011) 1.02
Testosterone exacerbates obstructive renal injury by stimulating TNF-alpha production and increasing proapoptotic and profibrotic signaling. Am J Physiol Endocrinol Metab (2007) 1.02
Arterially delivered mesenchymal stem cells prevent obstruction-induced renal fibrosis. J Surg Res (2010) 1.02
Estrogen receptor beta mediates acute myocardial protection following ischemia. Surgery (2008) 1.01
Stem cell mechanisms and paracrine effects: potential in cardiac surgery. Shock (2007) 1.01
Cell-based therapy for ischemic heart disease: a clinical update. Ann Thorac Surg (2009) 1.00
Inflammatory mediators and growth factors in obstructive renal injury. J Surg Res (2004) 1.00
The effects of estrogen on pulmonary artery vasoreactivity and hypoxic pulmonary vasoconstriction: potential new clinical implications for an old hormone. Crit Care Med (2008) 0.98
Mesenchymal stem cells attenuate hypoxic pulmonary vasoconstriction by a paracrine mechanism. J Surg Res (2007) 0.98
Activation of individual tumor necrosis factor receptors differentially affects stem cell growth factor and cytokine production. Am J Physiol Gastrointest Liver Physiol (2007) 0.98
Vascular endothelial growth factor improves myocardial functional recovery following ischemia/reperfusion injury. J Surg Res (2008) 0.97
P38 MAPK mediates myocardial proinflammatory cytokine production and endotoxin-induced contractile suppression. Shock (2004) 0.97
Exogenous estrogen rapidly attenuates pulmonary artery vasoreactivity and acute hypoxic pulmonary vasoconstriction. Shock (2008) 0.97
TNF-alpha neutralization decreases nuclear factor-kappaB activation and apoptosis during renal obstruction. J Surg Res (2006) 0.97
Stem cell therapy in myocardial repair and remodeling. J Am Coll Surg (2008) 0.96
Jak/STAT/SOCS signaling circuits and associated cytokine-mediated inflammation and hypertrophy in the heart. Shock (2006) 0.96
p38 mitogen activated protein kinase mediates both death signaling and functional depression in the heart. Ann Thorac Surg (2005) 0.96